Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Bajorin

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcomeH W Herr, D F Bajorin, H I Scher
The Journal of Urology|February 15, 2001
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerH W Herr, S M Donat, D F Bajorin
Current Therapy in Endocrinology and Metabolism|January 1, 1997
Germ cell tumorsD F Bajorin, R J Motzer, G J Bosl
Seminars in Oncology|April 1, 1992
"Poor-risk" germ cell tumors: current progress and future directionsR J Motzer, D F Bajorin, G J Bosl
World Journal of Surgery|March 1, 1992
Immunotherapy with monoclonal antibodies in metastatic melanomaT A Steffens, D F Bajorin, A N Houghton
Urologia Internationalis|January 1, 1991
Assessment of risk in metastatic testis carcinoma: impact on treatmentD F Bajorin, N L Geller, G J Bosl
The Urologic Clinics of North America|September 5, 1998
Risk assessment for metastatic testis cancerJ A McCaffrey, D F Bajorin, R J Motzer
Current Therapy in Endocrinology and Metabolism|January 1, 1994
Germ cell tumorsD F Bajorin, R J Motzer, G J Bosl
The Urologic Clinics of North America|September 5, 1998
Poor-risk germ cell tumors. Recent developmentsP M Dodd, R J Motzer, D F Bajorin
Seminars in Hematology|April 1, 1991
Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapyD F Bajorin, N K Cheung, A N Houghton
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcomeH W Herr, D F Bajorin, H I Scher
The Journal of Urology|February 15, 2001
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerH W Herr, S M Donat, D F Bajorin
Current Therapy in Endocrinology and Metabolism|January 1, 1997
Germ cell tumorsD F Bajorin, R J Motzer, G J Bosl
Seminars in Oncology|April 1, 1992
"Poor-risk" germ cell tumors: current progress and future directionsR J Motzer, D F Bajorin, G J Bosl
World Journal of Surgery|March 1, 1992
Immunotherapy with monoclonal antibodies in metastatic melanomaT A Steffens, D F Bajorin, A N Houghton
Urologia Internationalis|January 1, 1991
Assessment of risk in metastatic testis carcinoma: impact on treatmentD F Bajorin, N L Geller, G J Bosl
The Urologic Clinics of North America|September 5, 1998
Risk assessment for metastatic testis cancerJ A McCaffrey, D F Bajorin, R J Motzer
Current Therapy in Endocrinology and Metabolism|January 1, 1994
Germ cell tumorsD F Bajorin, R J Motzer, G J Bosl
The Urologic Clinics of North America|September 5, 1998
Poor-risk germ cell tumors. Recent developmentsP M Dodd, R J Motzer, D F Bajorin
Seminars in Hematology|April 1, 1991
Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapyD F Bajorin, N K Cheung, A N Houghton
Pageof 10